Instruct: Identify the main category of Biorxiv papers based on the titles and abstracts
Query: A ganglioside-based senescence-associated immune checkpoint Senescent cells accumulate in aging tissues, and their elimination can favor healthy aging1-4. Therefore, therapeutic interventions targeting cellular senescence may be promising strategies for delaying or reversing a vast range of age-related diseases5. As cells of the immune system are responsible for senescent cell elimination6-11, a possible anti-aging and pro-healthspan treatment is the specific activation of the immune system to induce senescent cell clearance. However, whether this elimination is limited by an immune checkpoint leading to tolerance of senescence cells is currently unknown. Here, we show that cellular senescence, elicited by various stressors other than oncogenic activation, triggers immune escape toward natural killer (NK) cells, which may thus limit the use of anti-senescence immunotherapies. Moreover, using mass spectrometry, we reveal that senescent cells reshuffle their glycosphingosine composition, toward a marked increase in the ganglioside content, including the appearance of disialylated ganglioside GD3. This senescence associated GD3 overexpression results from transcriptional upregulation of the gene encoding the enzyme ST8SIA1, which is responsible for GD3 synthesis. The high level of GD3 leads to a strong immunosuppressive signal affecting NK cell-mediated immunosurveillance. In a mouse model of lung fibrosis, senescent cell-dependent NK cell immunosuppression is blunted by in vivo administration of anti-GD3 monoclonal antibodies leading to a clear anti-fibrotic effect. These results demonstrate that GD3 upregulation in senescent cells drives a switch from immune clearance toward immune tolerance of senescent cells. Therefore, we propose that GD3 level acts as a senescence-associated immune checkpoint (SIC) that regulates NK cell functions toward senescent cells. Thus, targeting GD3 with specific antibodies may be a promising strategy for the development of effective anti-senescence immunotherapies.
7
The categories of this paper are: ecology
27
The categories of this paper are: pathology
25
The categories of this paper are: bioengineering
20
The categories of this paper are: pharmacology
30
The categories of this paper are: scientific
19
The categories of this paper are: epidemiology
10
The categories of this paper are: and
3
The categories of this paper are: evolutionary
5
The categories of this paper are: cell
8
The categories of this paper are: genomics
6
The categories of this paper are: plant
24
The categories of this paper are: cancer
29
The categories of this paper are: education
14
The categories of this paper are: biophysics
13
The categories of this paper are: animal
31
The categories of this paper are: paleontology